[1] Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents-an IDF consensus report[J]. Pediatr Diabetes, 2007, 8(5):299-306. [2] Grandl G, Wolfrum C. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome[J]. Semin Immunopathol, 2018,40(2):215-224. [3] Hsieh CJ, Wang PW, Chen TY. The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults[J]. Diabetol Metab Syndr, 2014,6(1):49. [4] Yoshinaga R, Doi Y, Ayukawa K, et al. High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department:A retrospective cohort study[J]. BMJ Open, 2017,7(10):e15112. [5] Shannon A, Alkhouri N, Carter-Kent C, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD[J]. J Pediatr Gastro enterol Nutr,2011, 53(2):190-195. [6] Koo DJ, Lee MY, Jung I, et al. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes:A cohort study[J]. PLoS One, 2021,16(8):e255535. [7] Li H, Ji CY, Zong XN, et al. Body mass index growth curves for Chinese children and adolescents aged 0-18 years[J]. Chin J Pediatr, 2009, 47:493-498. [8] Ji CY, Sung Rita YT, Ma GS, et al. Waist Circumference Distribution of Chinese School-age Children and Adolescents[J]. Biomed Environ Sci, 2010, 23:12-20. [9] 中国肥胖问题工作组.中国学龄儿童青少年超重、肥胖筛查体重指数值分类标准[J].中华流行病学杂志, 2004, 25(2):97-101. Group of China Obesity Task Force:Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents [J].Chin J Epidemiol,2004, 25(2):97-102. [10] Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood[J]. Pediatrics, 2008, 122:198-208. [11] 胡亚美, 江载芳. 诸福棠实用儿科学[M]. 7版. 北京:人民卫生出版社, 2002. Hu YM, Jiang ZF. Zhu Futang textbook of pediatrics [M]. 7th Ed. Beijing:People's Medical Publishing House, 2002. [12] Andrade R, Gigante DP, de Oliveira IO, et al. C-peptide and cardiovascular risk factors among young adults in a southern Brazilian cohort[J]. BMC Endocr Disord, 2018,18(1):80. [13] Koziarska-Ros'ciszewska M, Gluba-Brzózka A, Franczyk B, et al. High-sensitivity C-reactive protein relationship with metabolic disorders and cardiovascular diseases risk factors[J]. Life (Basel), 2021,11(8). [14] Wang Z, Wang X, Chen Z, et al. Distribution of high-sensitivity C-reactive protein and its relationship with other cardiovascular risk factors in the middle-aged chinese population[J]. Int J Environ Res Public Health, 2016,13(9):872. [15] Smitka K, Marešová D. Adipose tissue as an endocrine organ:An update on pro-inflammatory and anti-inflammatory microenvironment[J]. Prague Med Rep, 2015, 116:87-111. [16] Oruc N, Ozutemiz O, Yuce G, et al. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease:A case control study[J]. BMC Gastroenterol, 2009, 9:16-916. [17] Liu W, Baker RD, Bhatia T, et al. Pathogenesis of nonalcoholic steatohepatitis[J]. Cell Mol Life Sci, 2016, 73(10):1969-1987. [18] Huang G, Xu J, Zhang T, et al. Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu[J]. Scientific reports, 2020,10(1):8678. [19] 李自云,刘波,季业,等. 2型糖尿病患者血尿酸水平与超敏C反应蛋白的关系[J]. 中华医学杂志,2017,97(28):2181-2185. Li ZY, Liu B, Ji Y, et al.Association between serum uric acid levels and high sensitive C-reactive protein in patients with type 2 diabetes[J].Chinese Medical Journal,2017,97(28):2181-2185. [20] Kasliwal RR, Bansal M, Desai D, et al. Carotid intima-media thickness:Current evidence, practices, and Indian experience[J]. Indian J Endocrinol Metab, 2014,18(1):13-22. [21] Juonala M, Singh GR, Davison B, et al. Childhood metabolic syndrome, inflammation and carotid intima-media thickness. The aboriginal birth cohort study[J]. Int J Cardiol, 2016,203:32-36. |